G. Weldon Gilcrease, MD

G. Weldon Gilcrease, MD, is an instructor of medicine in the oncology division at the University of Utah School of Medicine as well as a Huntsman Cancer Institute (HCI) investigator. He specializes in gastrointestinal cancers and patients enrolled in early phase clinical trials.

Gilcrease's research focuses on early phase clinical trials and drug development. He is involved in preclinical research and Phase I/II trials for patients with inoperable colorectal cancer. His research entails exploiting important pathways that drive cancer, including the beta-catenin pathway in colorectal cancer, to develop novel and targeted therapies that will benefit patients.

Gilcrease completed a hematology/oncology fellowship at the University of Utah and HCI. In 2011, he was awarded the Outstanding Fellow Teaching Award. He completed his residency at Scripps Mercy Hospital in San Diego where he received the Outstanding Resident Award for his medical care and dedication to learning and teaching. He also served as Chief Resident. He earned a medical degree from the University of Arizona.